Skip to main content

D. E. Shaw & Co., Inc.

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1009207 New York, NY

Position in VRDN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$24,695,281
-$6,447,031 QoQ
Shares Held
1,262,540
+26.2% QoQ
Ownership
1.22%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

D. E. Shaw & Co., Inc. holds $4,371,472,260 across 180 Biotechnology names. VRDN ranks #36 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VRDN

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $24,695,281 1,262,540
2025-12-31 $31,142,312 1,000,717
2025-03-31 $1,097,042 81,383
2024-12-31 $8,474,481 442,070
2024-09-30 $3,141,024 138,067
2022-12-31 $9,877,858 338,167
2022-09-30 $12,885,920 628,275
2022-06-30 $8,783,110 759,128
2022-03-31 $14,479,426 783,095
2021-12-31 $15,116,399 764,613
2021-09-30 $11,852,718 720,530
2021-06-30 $13,175,622 720,373
2021-03-31 $3,150,035 188,512